In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Concomitant diabetes with atrial fibrillation and anticoagulation management considerations

ESC Council on Stroke webinar

24/11/2020 18:00 24/11/2020 19:00 Europe/Paris Concomitant diabetes with atrial fibrillation and anticoagulation management considerations

Access event page

ESC Councils contact@escardio.org DD/MM/YYYY
Diabetes and the Heart
Stroke Prevention
ESC Councils
Stroke
Online
event

Summary

Join Assoc. Prof. Tatjana Potpara, Prof. Peter Rossing and Dr. Renate Schnabel.

Free for everyone

Focus on

Learning objectives

After watching the webinar, participants will be able to:

  • Increase understanding of risk and complications that concern patients with atrial fibrillation (AF) who has concomitant diabetes (It is more than a ‘1’ score in CHADS2-VAsc) by focusing on the evidence that points out that diabetes is an independent risk factor for AF, together with: worse AF symptoms, lower quality of life, higher mortality and hospitalization rates;
  • Explain the increased cerebrovascular and cardiovascular complications of this cooccurrence and discuss the evidence related to anticoagulation in terms of mortality and morbidity by translating evidence from diabetic subgroups of pivotal NOAC trials as well as observational studies of oral anticoagulants, focusing on, stroke and systemic embolism and management of anticoagulation, Cardiovascular mortality, Major adverse cardiovascular and limb events; and
  • Explore not only macrovascular but also microvascular complications of diabetes, particularly kidney disease, and clinical implications of having concomitant CKD under anticoagulation therapy by explaining underlying mechanisms, risks and optimal management of patients who have or are under risk of developing kidney disease, with these three subtopics: Diabetic nephropathy, anticoagulation related nephropathy and vascular calcification theory.

Measure how much you learn from this webinar by taking the pre and post evaluation.



Register now

Free for everyone

Faculty

Speakers

Potpara-Tatjana-2018.pngAssociate Professor Tatjana Potpara, FESC
Department for Intensive Care in Cardiac Arrhythmias
University of Belgrade
Belgrade, Serbia

rossing-peter-2019.jpgProfessor Peter Rossing
Clinical Research
Steno Diabetes Center Copenhagen
Gentofte, Denmark

Host

2019-Renate-Schnabel.jpgDoctor Renate Schnabel
University Heart Center
Hamburg, Germany

 

Session information

This webinar is designed for general physicians and cardiologists, who care for patients with cardiovascular disease and with common comorbidities, who treat patients with anticoagulation with antiplatelet therapies depending on the patients underlying disease.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

An application has been made to the EACCME® for CME accreditation of this event.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live event, you must allow pop-up windows on your device.

A high-speed Internet connection is required (minimum 2 Mbps).